Ivermaxx 15 mg

When used for a confirmed infection that responds to ivermectin, Ivermaxx 15 mg can:

• Reduce the number of susceptible parasites

• Help clear certain intestinal parasite infections

• Control parasite-related skin symptoms

• Reduce further harm caused by untreated infection

• Provide a fixed strength for weight-based treatment

The treatment result depends on the parasite involved and whether the complete calculated dose is taken correctly. Follow-up testing is required for some infections to confirm parasite clearance.

COVID-19 and cancer research has helped scientists examine additional actions of ivermectin. However, these investigations have not established a treatment benefit for people using Ivermaxx 15 mg for either condition.

Ivermectin binds to specialised chloride channels in the nerve and muscle cells of susceptible parasites. This increases chloride movement into the cells and interrupts normal nerve activity.

The affected parasites become paralysed and die or are gradually removed from the body. The medicine works only against parasites that are sensitive to ivermectin. It does not treat every worm infection or infections caused by bacteria and fungi.

Laboratory researchers are examining whether ivermectin also influences processes connected with viral activity, cancer-cell survival and immune responses. Findings from cells or experimental models cannot be treated as proof of the same effect in patients.

Ivermaxx 15 mg dosage is calculated using body weight, the diagnosed parasite, medical history and the required treatment schedule. The tablet strength alone should not be used to decide how much ivermectin to take.

For strongyloidiasis, medical prescribing references commonly use a single dose of approximately 200 micrograms per kilogram of body weight. For onchocerciasis, approximately 150 micrograms per kilogram is commonly used. These dosing references are not instructions for choosing a personal dose.

Swallow the prescribed dose with water. Many oral ivermectin labels direct patients to take it on an empty stomach. Some conditions require follow-up testing or a repeat dose after a defined interval.

Do not split the tablet unless it is designed for splitting and the required amount has been confirmed. Do not repeat a dose because symptoms continue. There is no established Ivermaxx 15 mg dosage for COVID-19 or cancer, as the clinical trials are still ongoing.

Common Side Effects: Ivermaxx 15 mg can cause nausea, diarrhoea, stomach discomfort, reduced appetite, dizziness, headache, weakness, itching or a mild skin rash. Fever, joint discomfort, swollen lymph nodes or temporary worsening of skin symptoms can occur when the body reacts to dying parasites. Contact a healthcare professional if these effects continue or become troublesome.

Serious Side Effects: Seek urgent medical attention for breathing difficulty, facial or throat swelling, a severe or blistering rash, fainting, seizures, confusion, difficulty walking, extreme sleepiness, significant vision changes or yellowing of the skin or eyes. A heavy Loa loa infection can increase the risk of a serious neurological reaction following ivermectin treatment.

Medical assessment is required before taking Ivermaxx 15 mg for:

• People allergic to ivermectin

• Children weighing below 15 kg

• Pregnant or breastfeeding women

• People with significant liver problems

• People at risk of Loa loa infection

• People taking warfarin

• People using strong sedatives

• People receiving cancer treatment

• People considering COVID-19 self-treatment

• People considering cancer self-treatment

Tell the healthcare professional about all medicines, supplements and herbal products being used.

Important interactions requiring review include:

• Warfarin and other anticoagulants

• Sedatives and sleeping medicines

• Certain antifungal medicines

• Macrolide antibiotics

• HIV protease inhibitors

• Anti-seizure medicines

• Other antiparasitic treatments

• Chemotherapy and immunotherapy

Warfarin users can require additional blood-clotting tests. Do not combine Ivermaxx with another antiparasitic treatment or take an additional dose without medical instructions.

• Keep the tablets in their original strip.

• Follow the storage temperature printed on the pack.

• Store in a cool and dry place.

• Protect from direct sunlight and moisture.

• Keep away from children and pets.

• Do not use tablets from damaged packaging.

• Check the expiry date before use.

• Dispose of expired tablets according to local guidance.